ScrutarSign up free

FATE THERAPEUTICS INC (FATE)

SEC filings, insider trading & institutional ownership from EDGAR.

NasdaqHealth CareBiotechnology

Couldn’t find the data you were looking for?

We haven’t added FATE THERAPEUTICS INC’s filings yet. We add companies and filings all the time.

Track FATE and we’ll email you the moment its filings are in, free and with no account. Or create a free account to request coverage.

Institutions
33
$291.92M held

Latest filings

10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR

All filings →

No filings are available yet.

Top holders

13F & 13D/G • latest quarter

All →
HolderFiledValue
AllianceBernstein L.P.May 15, 2026$184.43M
BlackRock, Inc.Aug 7, 2026$19.71M
Vanguard Portfolio ManagementAug 13, 2026$12.27M
Vanguard Capital ManagementAug 13, 2026$12M
AQR CAPITAL MANAGEMENT LLCAug 14, 2026$10.36M

FATE's filings are public. The insight is one click away.

Scrutar's AI reads every FATE filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.

Analyze FATE filingsNo credit cardAI reports included on the free plan

Never miss a FATE filing.

Get an email when FATE files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.

Free foreverNo account requiredOne-click unsubscribe

Protected by reCAPTCHA. Privacy & Terms

Data as of Oct 16, 2026Source: SEC EDGAR.